BACKGROUND: With the global efforts of reducing pneumococcal disease through widespread introduction of pneumococcal vaccines, concerns have emerged on the potential increase of morbidity and mortality from S. aureus disease. Little is known however, of the carriage rates of S. aureus or of its' relationship with carriage of S. pneumoniae in rural Africa, and West Africa in particular where very high rates of carriage of S. pneumoniae have been reported. This study aims to evaluate the prevalence, antibiotic susceptibility patterns and genotypes of S. aureus isolated from the nasopharynx of healthy individuals in rural Gambia before the introduction of routine use of pneumococcal conjugate vaccines in the country. RESULTS: Overall prevalenc...
BACKGROUND: The study describes the molecular epidemiology of Streptococcus pneumoniae causing invas...
Abstract Background We conducted an ancillary study among individuals who had participated in a clus...
BACKGROUND. To prepare for national introduction of a pneumococcal vaccine of restricted valency, we...
Staphylococcus aureus and Streptococcus pneumoniae commonly colonize the upper respiratory tract and...
AbstractStaphylococcus aureus and Streptococcus pneumoniae commonly colonize the upper respiratory t...
BACKGROUND: We conducted an ancillary study among individuals who had participated in a cluster-rand...
BACKGROUND: Streptococcus pneumoniae serotype 1 causes > 20% of invasive disease, among all age grou...
BACKGROUND: Streptococcus pneumoniae serotype 5 is among the most common serotypes causing invasive ...
BACKGROUND: Although Haemophilus influenzae type b (Hib), Staphylococcus aureus and Moraxella catarr...
BACKGROUND: To prepare for the introduction of a pneumococcal conjugate vaccine of restricted valenc...
BACKGROUND: We conducted an ancillary study among individuals who had participated in a PCV-7 trial ...
Staphylococcus aureus bacteremia is a substantial cause of childhood disease and death, but few stud...
BACKGROUND: The incidence of community-acquired bacteremia (CAB) in Africa is several-fold higher th...
Staphylococcus aureus bacteremia is a substantial cause of childhood disease and death, but few stud...
BACKGROUND. To prepare for national introduction of a pneumococcal vaccine of restricted valency, we...
BACKGROUND: The study describes the molecular epidemiology of Streptococcus pneumoniae causing invas...
Abstract Background We conducted an ancillary study among individuals who had participated in a clus...
BACKGROUND. To prepare for national introduction of a pneumococcal vaccine of restricted valency, we...
Staphylococcus aureus and Streptococcus pneumoniae commonly colonize the upper respiratory tract and...
AbstractStaphylococcus aureus and Streptococcus pneumoniae commonly colonize the upper respiratory t...
BACKGROUND: We conducted an ancillary study among individuals who had participated in a cluster-rand...
BACKGROUND: Streptococcus pneumoniae serotype 1 causes > 20% of invasive disease, among all age grou...
BACKGROUND: Streptococcus pneumoniae serotype 5 is among the most common serotypes causing invasive ...
BACKGROUND: Although Haemophilus influenzae type b (Hib), Staphylococcus aureus and Moraxella catarr...
BACKGROUND: To prepare for the introduction of a pneumococcal conjugate vaccine of restricted valenc...
BACKGROUND: We conducted an ancillary study among individuals who had participated in a PCV-7 trial ...
Staphylococcus aureus bacteremia is a substantial cause of childhood disease and death, but few stud...
BACKGROUND: The incidence of community-acquired bacteremia (CAB) in Africa is several-fold higher th...
Staphylococcus aureus bacteremia is a substantial cause of childhood disease and death, but few stud...
BACKGROUND. To prepare for national introduction of a pneumococcal vaccine of restricted valency, we...
BACKGROUND: The study describes the molecular epidemiology of Streptococcus pneumoniae causing invas...
Abstract Background We conducted an ancillary study among individuals who had participated in a clus...
BACKGROUND. To prepare for national introduction of a pneumococcal vaccine of restricted valency, we...